Fundraising Fox
Ancora Biotech
4 known investors
Find your way into Ancora Biotech
Sign up to see every warm intro you have to Ancora Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ancora Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ancora Biotech is a privately held biotherapeutics developer overseeing the manufacturing and clinical development of three multi-specific antibodies held in separate spin-offs. Its programs target B cell cancers, inflammatory and metabolic disorders, and chronic hepatitis B infections.
Investors · 4
Lightspeed Venture Partners✓ confirmed by Ancora BiotechMenlo Park · $1M – $5M
How we know: the company's own site · Lightspeed Venture Partners's portfolio page · funding news · venturecapitaljournal.com · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 1
SR Onelead
Frequently asked questions
- What does Ancora Biotech do?
- Ancora Biotech is a privately held biotherapeutics developer overseeing the manufacturing and clinical development of three multi-specific antibodies held in separate spin-offs. Its programs target B cell cancers, inflammatory and metabolic disorders, and chronic hepatitis B infections.
- Who are Ancora Biotech's investors?
- Ancora Biotech's investors include Lightspeed Venture Partners, Sutter Hill Ventures, SR One Capital Management.